David Eller, CEO of Celltex Therapeutics Corporation presents award to PhD Candidate, Ramon Coronado, Director of Lester Smith Medical Research Institute
Online, July 6, 2016 (Newswire.com) - Regenera Global announced Ramon Coronado, Director of the Lester Smith Medical Research Institute, as the recipient of the 2016 Celltex Outstanding Investigator Award at the "Regenerative Medicine 2.0: Redefining the Practice" Conference.
Celltex Therapeutics CEO, David Eller, presented the award to Ramon Coronado shortly after Mr. Coronado revealed his recent scientific discoveries to the physicians and research scientists gathered at the Freeport, Grand Bahama medical conference.
Coronado, a Ph.D. candidate at the University of Texas San Antonio/University of Texas Health Science Center, received his Masters of Science in Biomedical Engineering at UT San Antonio-UT Health Science Center, San Antonio, and is currently at the Transplant Center/US Army Institute of Surgical Research working on decellularized organs as substrates for stem cells.
"Mr. Coronado has an impressive background in biomedical research and we are proud to recognize his contributions the field," says Eller. "His work, as it pertains to human autologous and biological therapeutics, will fuel the advancement of much-needed medical innovation in the 21st century."
"We wish to thank Celltex Therapeutics for taking a leadership role in recognizing young innovators within the field of regenerative medicine," stated Luis Martinez, M.D. "This annual award will help foster ongoing research, and Regenera Global is pleased to work with Celltex Therapeutics to assist young researchers in achieving their goals."
The annual Celltex Award was created to recognize an investigator whose novel and significant work has had or may have a far-reaching impact on the clinical translation of Regenerative Medicine for health or anti-aging applications. Such work may involve any discipline across the continuum of biomedical research that remains in the parameters of basic, translational or clinical studies. Applications for the 2017 Celltex Outstanding Investigator Award will be available August 1 at regeneraglobal.com.
About Regenera Global, Inc.
Based in Puerto Rico, Regenera Global, Inc. is a bio-technology firm focused on developing and commercializing innovative therapies, providing consulting services and educational events to physicians and healthcare practitioners to expand their knowledge of regenerative medicine clinical applications which may include, but is not limited to, stem cell and gene therapy, tissue engineering, and select medical devices. Regenera Global is working to bridge the gap of access to regenerative medicine between the progress made through research and what is available clinically to physicians and patients.
Twitter: twitter.com/RegeneraGlobal
LinkedIn: www.linkedin.com/company/regenera-global?trk=biz-companies-cym
Google+: plus.google.com/117977749219422536232?hl=en
Facebook: www.facebook.com/RegeneraGlobal/
About Celltex Therapeutics Corporation
Celltex Therapeutics is a Houston-based biotechnology company that is leading the United States into the future of regenerative medicine with its proprietary technology that isolates, multiplies and stores autologous, adult, adipose (fat tissue)-derived mesenchymal stem cells (MSCs) to be used for regenerative therapy in a number of conditions including vascular, autoimmune and degenerative diseases. Celltex is committed to expanding the use of adult stem cell therapy for all and is currently working with leading American academic institutions on several clinical trials that will help secure the future of regenerative medicine here in the United States. For more information about Celltex Therapeutics Corporation, please visit www.celltexbank.com.
Media Contact:
Kathy Hebert
Regenera Global
info(at)regeneraglobal(dot)com
708-529-1549
Source URL: http://prweb.com/releases/2016/07/prweb13526996.htm
Share: